These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9152390)

  • 41. Degradation of deltorphins and their analogs by rat brain synaptosomal peptidases.
    Sasaki Y; Chiba T; Ambo A; Suzuki K
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):592-4. PubMed ID: 8004705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deltorphin analogs restricted via a urea bridge: structure and opioid activity.
    Zieleniak A; Rodziewicz-Motowidło S; Rusak L; Chung NN; Czaplewski C; Witkowska E; Schiller PW; Ciarkowski J; Izdebski J
    J Pept Sci; 2008 Jul; 14(7):830-7. PubMed ID: 18219707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, biological activity and resistance to proteolytic digestion of new cyclic dermorphin/deltorphin analogues.
    Bańkowski K; Witkowska E; Michalak OM; Sidoryk K; Szymanek E; Antkowiak B; Paluch M; Filip KE; Cebrat M; Setner B; Szewczuk Z; Stefanowicz P; Cmoch P; Izdebski J
    Eur J Med Chem; 2013 May; 63():457-67. PubMed ID: 23523659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, conformation and opioid activity of deltorphins.
    Ji H; Zhang R; Hu X; Lai L; Xu X
    Biochem Biophys Res Commun; 1995 Feb; 207(1):99-104. PubMed ID: 7857311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The biological consequences of replacing hydrophobic amino acids in deltorphin I with amphiphilic alpha-hydroxymethylamino acids.
    Olma A; Łachwa M; Lipkowski AW
    J Pept Res; 2003 Jul; 62(1):45-52. PubMed ID: 12787450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability of endomorphins and the blood-brain barrier--a review.
    Perlikowska R; Janecka A
    Med Chem; 2014; 10(1):2-17. PubMed ID: 23984851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of the proline residue to the functional activity and metabolic stability of the nematode FMRFamide-related peptide, KPNFIRFamide (PF4).
    Kubiak TM; Maule AG; Marks NJ; Martin RA; Wiest JR
    Peptides; 1996; 17(8):1267-77. PubMed ID: 8971918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood-brain barrier penetration by two dermorphin tetrapeptide analogues: role of lipophilicity vs structural flexibility.
    Ballet S; Misicka A; Kosson P; Lemieux C; Chung NN; Schiller PW; Lipkowski AW; Tourwé D
    J Med Chem; 2008 Apr; 51(8):2571-4. PubMed ID: 18370374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Localization of [D-Ala2]deltorphin I-like immunoreactivity in perinatal rat respiratory system.
    Matsui S; Fujimiya M; Matsui J; Amakata Y; Renda T; Kimura H; Maeda T
    Histochem J; 1994 Aug; 26(8):648-54. PubMed ID: 7982790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transient expression of [D-Ala2] deltorphin I-like immunoreactivity in prenatal rat small intestine.
    Matsui J; Fujimiya M; Matsui S; Amakata Y; Renda T; Kimura H; Maeda T
    J Histochem Cytochem; 1994 Oct; 42(10):1377-81. PubMed ID: 7930520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and analgesic activity evaluation of some agmatine derivatives.
    He H; Liu M; Zheng Z; Liu Y; Xiao J; Su R; Hu C; Li J; Li S
    Molecules; 2006 Jun; 11(6):393-402. PubMed ID: 17962772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deltorphin analogs restricted via a urea bridge: structure and opioid activity.
    Ciarkowski J; Zieleniak A; Rodziewicz-Motowidło S; Rusak Ł; Chung NN; Czaplewski C; Witkowska E; Schiller PW; Izdebski J
    Adv Exp Med Biol; 2009; 611():491-2. PubMed ID: 19400279
    [No Abstract]   [Full Text] [Related]  

  • 53. Hypoxic/Ischemic Inflammation, MicroRNAs and δ-Opioid Receptors: Hypoxia/Ischemia-Sensitive Versus-Insensitive Organs.
    Chen Y; He Y; Zhao S; He X; Xue D; Xia Y
    Front Aging Neurosci; 2022; 14():847374. PubMed ID: 35615595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The distribution of nifurtimox across the healthy and trypanosome-infected murine blood-brain and blood-cerebrospinal fluid barriers.
    Jeganathan S; Sanderson L; Dogruel M; Rodgers J; Croft S; Thomas SA
    J Pharmacol Exp Ther; 2011 Feb; 336(2):506-15. PubMed ID: 21057057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.
    Fagerholm U
    Pharm Res; 2008 Mar; 25(3):625-38. PubMed ID: 17710514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability.
    Gudmundsson OS; Pauletti GM; Wang W; Shan D; Zhang H; Wang B; Borchardt RT
    Pharm Res; 1999 Jan; 16(1):7-15. PubMed ID: 9950272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deltorphin transport across the blood-brain barrier.
    Fiori A; Cardelli P; Negri L; Savi MR; Strom R; Erspamer V
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9469-74. PubMed ID: 9256506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability.
    Thomas SA; Abbruscato TJ; Hau VS; Gillespie TJ; Zsigo J; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 May; 281(2):817-25. PubMed ID: 9152390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F
    J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.